Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03503669 · ClinicalTrials.gov registry record · NA

Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT03503669: Completed NA study, sponsored by University of California, Los Angeles.

NCT03503669 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03503669, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this pilot study will be to test whether Kundalini yoga (KY) and Kirtan Kriya (KK) yogic meditation is superior to Memory Enhancement Training (MET) for improving cognitive functioning, health (including cardiovascular factors), and mood in women with high AD risk.

Primary Outcome

Verbal memory was measured with the Hopkins Verbal Learning Test (HVLT) total recall scores. The HVLT form contains 12 nouns, four words each from one of three semantic categories (e.g., precious gems, articles of clothing, vegetables, etc.), to be learned over the course of three learning trials. When scoring the HVLT, the three learning trials are combined to calculate a total recall score. Total scores range from 0-36 with higher scores indicating better outcome.

Interventions

  • BEHAVIORAL Kundalini yoga and meditation
  • BEHAVIORAL Memory Training

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-05-01
Est. Completion 2021-02-01
Phase NA

What the finished NCT03503669 record still lists

NCT03503669 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Kundalini yoga and meditation is the first listed.

NCT03503669 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03503669 about?

NCT03503669 is a clinical study titled "Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training". The purpose of this pilot study will be to test whether Kundalini yoga (KY) and Kirtan Kriya (KK) yogic meditation is superior to Memory Enhancement Training (MET) for improving cognitive functioning, health (including cardiovascular factors), and mood in women with high AD risk.

What is the current status of trial NCT03503669?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-05-01. Estimated completion is 2021-02-01.

What interventions are being tested in trial NCT03503669?

The interventions under investigation include: Kundalini yoga and meditation (BEHAVIORAL), Memory Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03503669?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03503669's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03503669, the US trial registry maintained by the National Library of Medicine. NCT03503669 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.